Abstract
OBJECTIVE:This paper describes the clinical features, treatment indications, mortality and severity of global disability in the follow up outcomes in isquemic cerebrovascular stroke patients submitted to mechanical thrombectomy.
MATERIALS AND METHODS:Retrospective, descriptive, cross-sectional study conducted from April 2013 to April 2016.
RESULTS:During the study period, ten patients underwent mechanical thrombectomy. Mean age was 62, median modified Rankin Scale Score at acceptance was 4. Initially, all patients had a combined reperfusion approach, unless there were contraindications. Intravenous thrombolysis was contraindicated in 40% of patients. Mortality Trombectomía mecánica en pacientes con ataque cerebrovascular isquémico: serie de casos en un centro de referencia colombiano rate was 20% as well as intraparenchimal hemorrhage. Modified Rankin Scale improved during follow up in 70% of patients. Of these, functional independence was achieved by 50% of patients.
CONCLUSION:it seems to be a functional independence impact on patients submitted to mechanical thrombectomy. There is not difference in safety and mortality outcomes.
References
Departamento Administrativo Nacional de Estadística de Colombia. [Internet]. Bogotá, Colombia. Disponible en: www dane.gov.co
Silva FA, Zarruk JG, Quintero C, Arenas W, Silva SY Enfermedad cerebro-vascular en Colombia. Rev Colom Cardiol. 2006;13(2):85-89.
Villa M, Massaro M, Bareño J, Franco C. La edad y factores clínicos aso-ciados al desenlace funcional a seis meses en pacientes con ataque cere-brovascular isquémico atendidos durante el 2011 en el Instituto Neurológico de Colombia. Acta Neurol Colomb. 2015;31(2):167-75.
Broderick JP, Palesch YY, Demchuk AM, et al. Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903.
Kidwell CS, Jahan R, Gornbein J, Algeret JR, Nenov V, Ajani Z; et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914-923. http://dx.doi.org/10.1056/NEJMoa1212793
Chen CJ, Ding D, Starke RM, Mehndiratta P, Crowley RW, Liu KC, et al; En-dovascular vs medical management of acute ischemic stroke. Neurology. 2015;85(22):1980-90. http://dx.doi.org/10.1212/WNL.0000000000002176
Touma L, Filion KB, Sterling LH, Atallahr, Windle SB, Eisen-berg MJ. Stent retrievers for the treatment of acute ischemic stroke: a systematic review and meta-analysis of randomized clinical trials. JAMA Neurol. 2016;73(3):275-81. http://dx.doi.org/10.1001/jamaneurol.2015.4441
Campbell BC, Hill MD, Rubiera M, Menon BK, Demchuk A, Donnan GA, et al. Safety and efficacy of solitaire stent thrombectomy: Individual patient da-ta meta-analysis of randomized trials. Stroke;47(3):798-806. doi: http://dx.doi.org/10.1161/STROKEAHA
Torres J, Fonnegra J, Vicini Javier. Terapia endovascular en el tratamiento del ACV isquémico agudo. Perspectiva en Colombia. Acta Neurol Colomb. 31(3):335-41.
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial ofintra-arterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. http://dx.doi.org/10.1056/NEJMoa1411587
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30. http://dx.doi.org/10.1056/NEJMoa1414905
Campbell Bcv, Mitchell Pj, Kleinig TJ, Kleiniget TJ, Dewey H, Churilov L, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Eng J Med. 2015;372(11):1009-18. http://dx.doi.org/10.1056/NEJMoa1414792
Saver Jl, Goyal M, Bonafe A, Dieneret HC, Elad I. Levy E, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-95. http://dx.doi.org/10.1056/NEJMoa1415061
Jovin Tg, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-06. http://dx.doi.org/10.1056/NEJMoa1503780
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.